The fact that plasma levels of PAPP-A are apparently not detectable in a significant proportion of normal pregnancies at 5-6 weeks suggests it would seem unlikely plasma PAPP-A could be relied upon as a clinical biomarker for miscarriage. This evidence concerns the gene PAPPA and spontaneous abortion.